OnBio Limited 9226874 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is renewable energy equipment supply Digita Accounts Production Advanced 6.30.9574.0 true 9226874 2025-01-01 2025-12-31 9226874 2025-12-31 9226874 core:RetainedEarningsAccumulatedLosses 2025-12-31 9226874 core:ShareCapital 2025-12-31 9226874 core:CurrentFinancialInstruments 2025-12-31 9226874 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 9226874 core:Non-currentFinancialInstruments 2025-12-31 9226874 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 9226874 core:FurnitureFittingsToolsEquipment 2025-12-31 9226874 core:MotorVehicles 2025-12-31 9226874 bus:SmallEntities 2025-01-01 2025-12-31 9226874 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 9226874 bus:FilletedAccounts 2025-01-01 2025-12-31 9226874 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 9226874 bus:RegisteredOffice 2025-01-01 2025-12-31 9226874 bus:Director1 2025-01-01 2025-12-31 9226874 bus:Director2 2025-01-01 2025-12-31 9226874 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 9226874 bus:Agent1 2025-01-01 2025-12-31 9226874 core:FurnitureFittingsToolsEquipment 2025-01-01 2025-12-31 9226874 core:MotorVehicles 2025-01-01 2025-12-31 9226874 core:PlantMachinery 2025-01-01 2025-12-31 9226874 core:Vehicles 2025-01-01 2025-12-31 9226874 countries:EnglandWales 2025-01-01 2025-12-31 9226874 2024-12-31 9226874 core:FurnitureFittingsToolsEquipment 2024-12-31 9226874 core:MotorVehicles 2024-12-31 9226874 2024-01-01 2024-12-31 9226874 2024-12-31 9226874 core:RetainedEarningsAccumulatedLosses 2024-12-31 9226874 core:ShareCapital 2024-12-31 9226874 core:CurrentFinancialInstruments 2024-12-31 9226874 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 9226874 core:Non-currentFinancialInstruments 2024-12-31 9226874 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 9226874 core:FurnitureFittingsToolsEquipment 2024-12-31 9226874 core:MotorVehicles 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 9226874

OnBio Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2025

 

OnBio Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

4 to 8

 

OnBio Limited

Company Information

Directors

Mr T C Crooke

Mrs S J Crooke

Registered office

Handy Cross Farm
Wycombe Road
High Wycombe
HP10 9QD

Accountants

Landmark Accountants Limited Leavesden Park
5 Hercules Way
Watford
Hertfordshire
WD25 7GS

 

OnBio Limited

(Registration number: 9226874)
Balance Sheet as at 31 December 2025

Note

2025

Restated
2024

   

£

£

£

£

Fixed assets

   

 

Tangible assets

4

 

1,138,822

 

939,018

Current assets

   

 

Stocks

5

103,535

 

118,869

 

Debtors

6

659,728

 

385,705

 

Cash at bank and in hand

 

660,466

 

593,499

 

 

1,423,729

 

1,098,073

 

Creditors: Amounts falling due within one year

7

(631,722)

 

(363,598)

 

Net current assets

   

792,007

 

734,475

Total assets less current liabilities

   

1,930,829

 

1,673,493

Creditors: Amounts falling due after more than one year

7

 

-

 

(150,000)

Provisions for liabilities

 

(284,706)

 

(234,755)

Net assets

   

1,646,123

 

1,288,738

Capital and reserves

   

 

Called up share capital

2

 

2

 

Retained earnings

1,646,121

 

1,288,736

 

Shareholders' funds

   

1,646,123

 

1,288,738

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 June 2026 and signed on its behalf by:
 

 

OnBio Limited

(Registration number: 9226874)
Balance Sheet as at 31 December 2025

.........................................
Mr T C Crooke
Director

 

OnBio Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Handy Cross Farm
Wycombe Road
High Wycombe
HP10 9QD

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentational currency of these accounts is £ Sterling. The level of rounding is to nearest £.

Prior period errors

The adjustment relates to the recognition of deferred tax as required under FRS 102. The director deems it necessary to adjust the comparatives.

Relating to the current period disclosed in these financial statements
£

Relating to the prior period disclosed in these financial statements
£

Relating to periods before the prior period disclosed in these financial statements
£

Deferred tax charged to the P&L account

-

234,755

-

Origination and reversal of timing differences

-

(234,755)

-

   

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

OnBio Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery (owned)

25% reducing balance

Motor vehicles

25% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

 

OnBio Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments.
 Recognition and measurement
Basic financial instruments are recognised at amortised cost.
 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2024 - 12).

 

OnBio Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

4

Tangible assets

Plant and machinery (owned)
£

Motor vehicles
 £

Total
£

Cost or valuation

At 1 January 2025

1,602,975

14,540

1,617,515

Additions

498,663

18,893

517,556

Disposals

(42,695)

-

(42,695)

At 31 December 2025

2,058,943

33,433

2,092,376

Depreciation

At 1 January 2025

677,375

1,122

678,497

Charge for the year

295,591

4,929

300,520

Eliminated on disposal

(25,463)

-

(25,463)

At 31 December 2025

947,503

6,051

953,554

Carrying amount

At 31 December 2025

1,111,440

27,382

1,138,822

At 31 December 2024

925,600

13,418

939,018

5

Stocks

2025
£

2024
£

Other inventories

103,535

118,869

6

Debtors

Current

2025
£

2024
£

Trade debtors

547,656

295,013

Prepayments

106,972

40,492

Other debtors

5,100

50,200

 

659,728

385,705

 

OnBio Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

7

Creditors

2025
£

2024
£

Due within one year

Trade creditors

324,748

162,867

Taxation and social security

244,503

198,199

Accruals and deferred income

52,469

765

Other creditors

10,002

1,767

631,722

363,598

8

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Other borrowings

-

150,000